Group I
Hypoplasia/absence of brainstem nuclei: Brainstem nuclei including the abducens and facial nerve nuclei are not formed or are significantly reduced in size.
Möbius syndrome is a rare congenital disorder characterized by non-progressive facial muscle paralysis and horizontal gaze palsy due to congenital dysfunction of the 6th (abducens) and 7th (facial) cranial nerves. It is classified under Congenital Cranial Dysinnervation Disorders (CCDDs) 1).
Incidence is estimated at 1 in 50,000 to 500,000 births. There is no sex predilection. Most cases are sporadic, but rare autosomal dominant families have been reported. It is usually bilateral abducens nerve palsy, but can be unilateral. When accompanied by limb abnormalities, it is called Poland-Möbius syndrome.
Pathologically, hypoplasia or atrophy of brainstem nuclei including the abducens nucleus is observed. The NINDS pathological classification categorizes it into the following four groups.
Group I
Hypoplasia/absence of brainstem nuclei: Brainstem nuclei including the abducens and facial nerve nuclei are not formed or are significantly reduced in size.
Group II
Peripheral nerve degeneration: The main feature is neuronal loss and degeneration in the peripheral facial nerve.
Group III
Necrosis/sclerosis of nerve nuclei: In addition to neuronal loss and degeneration in brainstem nuclei, there are microlesions and sclerosis.
Group IV
No cranial nerve lesions: There are no clear cranial nerve lesions, and muscle symptoms are predominant.
It is a rare disease estimated to occur in 1 in 50,000 to 500,000 births. There is no gender difference, and most cases are sporadic with low heritability, but rare autosomal dominant families have been reported.
In many cases, the diagnosis is made during infancy based on poor feeding, incomplete eyelid closure, mask-like facies, and hypoplasia of the tongue.
Associated cranial nerve lesions that may occur are listed below.
| Cranial Nerve | Clinical Symptoms Due to Impairment |
|---|---|
| CN5 (Trigeminal nerve) | Facial sensory disturbance |
| CN8 (Vestibulocochlear nerve) | Sensorineural hearing loss |
| CN10 (Vagus nerve) | Dysphagia and dysarthria |
| CN12 (Hypoglossal nerve) | Tongue atrophy and dysarthria |
Horizontal eye movement is impaired, but vertical (up and down) movement is preserved1). Severity varies among individuals, ranging from cases with only abduction limitation to complete horizontal gaze palsy.
Several hypotheses have been proposed regarding the etiology of Möbius syndrome, and it is considered multifactorial rather than having a single cause.
Pathologically, hypoplasia or atrophy of brainstem nuclei including the abducens nucleus is observed. Although often sporadic, autosomal dominant inheritance has also been reported.
Most cases are sporadic, and the disease is not easily inherited. Multiple etiological hypotheses have been proposed, including PLXND1 and ECEL1 gene mutations and exposure to teratogenic substances in early pregnancy. Rare familial cases with dominant inheritance have been reported, but even in familial cases, they often do not meet the full diagnostic criteria1).
The diagnosis of Möbius syndrome is primarily clinical. There is currently no universally accepted diagnostic criteria.
Representative differential diagnoses are shown below.
| Disease | Key Points for Differentiation |
|---|---|
| Duane syndrome | Abduction deficit + globe retraction and palpebral fissure narrowing on adduction. Unilateral in 82%, more common in the left eye. No facial palsy. |
| CFEOM (Congenital Fibrosis of the Extraocular Muscles) | Ptosis and limited elevation are predominant1). Horizontal movement disorder is not a main symptom. |
| HGPPS (Horizontal Gaze Palsy with Progressive Scoliosis) | Both abduction and adduction are impossible, but no globe retraction1). Association with scoliosis is characteristic. |
There is no curative treatment. Symptomatic treatment is the mainstay, and an interdisciplinary approach involving ophthalmology, plastic surgery, and dentistry is necessary.
The highest priority is preventing corneal damage due to incomplete eyelid closure from facial nerve palsy.
For esotropia, bilateral medial rectus muscle recession is the first choice. Additional surgeries such as lateral rectus resection or vertical rectus muscle transposition are selected as needed.
Gracilis muscle transfer may restore facial muscle function and enable smiling. Collaboration with plastic surgery is necessary, and it is not indicated for all cases.
The pathophysiology of Moebius syndrome is understood within the framework of CCDDs. The main pathogenic mechanisms are the following two 1).
(a) Impaired specification of neurons
The sequential expression of transcription factors required for brainstem patterning is disrupted, leading to the loss of specific motor nuclei (CN6 and CN7 nuclei). In this mechanism, the developmental ‘map’ of the brainstem itself is not formed, resulting in the absence of target nuclei.
(b) Impaired axon growth and guidance
Neurons are present, but the axons of cranial nerves cannot reach the target muscles. Misrouting may cause innervation of muscles different from the intended ones.
The PLXND1 gene encodes the membrane receptor protein plexin D1, which is involved in neural vascular formation and motor neuron migration and proliferation 1). An association with Moebius syndrome has been suggested.
Regarding mutations in the ECEL1 (endothelin-converting enzyme-like 1) gene, the following has been shown in mouse models 1).
PLXND1 and ECEL1 are independent genes; C760R and G607S mutations have been reported as mutations in ECEL1.
The CN6 and CN7 nuclei are located in the brainstem watershed region (a border zone with fragile blood supply), making them particularly vulnerable to ischemia. Transient ischemia due to teratogens or vascular abnormalities can lead to necrosis of these cranial nerve nuclei.
Due to the anatomical relationship where CN7 runs near the CN6 nucleus in the pons, both nerves are prone to simultaneous damage2).
MacKinnon et al. (2014) reported that most cases of Möbius syndrome are sporadic, and even familial cases often do not meet the full diagnostic criteria (some cases present with facial palsy alone without abduction deficit)1).
A possible association with tubulinopathies has also been suggested, and a family with autosomal dominant bilateral facial palsy, ptosis, and velopharyngeal dysfunction has been reported1).
Functional analysis of CCDD-related genes including ECEL1 and PLXND1 is progressing. Elucidation of axon guidance abnormalities in mouse models is deepening the understanding of the genetic basis of CCDDs, including Möbius syndrome1).
Nagata et al. (2017) reported that the C760R and G607S mutations in ECEL1 cause abducens nerve axon guidance abnormalities through different molecular mechanisms (abnormal protein localization and mRNA degradation)1).
The identification of causal genes associated with CCDDs is progressing, and research continues to elucidate the genetic diversity and pathophysiological mechanisms of congenital cranial dysinnervation disorders, including Moebius syndrome 1).
It has been suggested that the disease spectrum of tubulinopathies may extend to CCDDs, and further detailed elucidation through future genetic analysis studies is expected 1).
Whitman MC. Axon guidance deficits cause cranial nerve dysinnervation disorders (CCDDs). Annu Rev Vis Sci. 2020;6:819-842.
American Academy of Ophthalmology. Adult Strabismus Preferred Practice Pattern. Ophthalmology. 2020.